查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1948821

DNA擴增試劑盒市場－全球產業規模、佔有率、趨勢、機會及按類型、應用、地區和競爭格局分類的預測（2021-2031年）

DNA Amplification Kit Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type ( PCR, Isothermal Amplification), By Application (Clinical, Research), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球DNA擴增試劑盒市場預計將從2025年的11.5031億美元成長到2031年的16.7563億美元，複合年成長率為6.47%。

這些試劑盒包含用於目標核酸序列指數級複製的專用酵素混合物和試劑組，在臨床診斷和生命科學研究中發揮至關重要的作用。市場成長的根本驅動力是感染疾病日益普遍以及分子診斷在個人化癌症治療中日益廣泛的應用。這些持續的促進因素確保了長期需求，而非供應鏈轉移和短期監管變化等暫時性的產業波動。

市場概覽
預測期 2027-2031
市場規模：2025年 11.5031億美元
市場規模：2031年 16.7563億美元
複合年成長率：2026-2031年 6.47%
成長最快的細分市場 PCR
最大的市場 北美洲

儘管前景樂觀，但先進擴增設備所需的大量資本投入，對資源匱乏地區的市場成長構成重大障礙。這一經濟壁壘限制了發展中地區的市場准入，阻礙了自動化解決方案的廣泛應用。 MedTech Europe 預測，到 2024 年，歐洲醫療技術市場規模將達到 1,700 億歐元，其中體外診斷將成為最大的細分市場，這體現了該行業的經濟規模。該數據也印證了診斷產業的經濟規模，而 DNA 擴增產品在該產業中發揮關鍵作用。

市場促進因素

遺傳性疾病和感染疾病率的上升是全球DNA擴增試劑盒市場的主要驅動力，持續推動對分子診斷工具的需求。隨著結核病和呼吸道病毒等病原體帶來的全球健康挑戰不斷加劇，人們對聚合酵素鏈鎖反應（PCR）等精準檢測方法的依賴性顯著增強。這種依賴性也體現在主要診斷設備製造商的財務表現中，這些製造商提供必要的試劑和酵素。例如，凱傑公司在2025年2月發布的「2024年第四季及全年財務表現」報告中指出，其診斷解決方案，特別是QIAstat-Dx和QuantiFERON產品線，實現了兩位數的成長，凸顯了可靠檢測基礎設施的緊迫性。

同時，生物技術和製藥業的強勁研發擴張推動了藥物發現和基因測序所需擴增試劑盒的消費。生物製藥公司正投入大量資金開發標靶治療，而這需要大量的耗材用於檢驗和基因分析。羅氏公司2025年1月發布的「2024年報告」顯示，其研發支出達到130億瑞士法郎，並印證了這項財務投入。這種研發主導的環境確保了製造商穩定的收入來源。 Illumina公司2025年2月發布的「10-K表格」報告顯示，其核心耗材銷售額達31.7億美元，這充分體現了試劑類產品在基因組學生態系統中的巨大價值。

市場挑戰

先進擴增設備所需的大量資本投入是全球DNA擴增試劑盒市場成長的主要障礙。雖然試劑盒本身是持續消耗的耗材，但其有效利用完全依賴昂貴的自動化處理平台和聚合酵素連鎖反應熱迴圈儀。在資源匱乏的環境中，無力資金籌措這部分初始基礎建設費用會造成瓶頸，阻礙後續試劑的購買。因此，製造商無法觸及發展中地區的大部分潛在客戶，這限制了試劑盒的總銷量，儘管這些地區對診斷有著迫切的臨床需求。

產業內不斷上漲的營運成本加劇了這種財務壓力，阻礙了設備價格的大幅下降。根據 MedTech Europe 於 2025 年發布的調查數據，體外診斷試劑製造商在五年周期內，其再認證和監管維護支出將增加 70%。如此顯著的營運成本成長限制了製造商降低新檢查室進入門檻的柔軟性。因此，進入門檻依然很高，直接限制了 DNA 擴增技術的廣泛應用。

市場趨勢

製造商正在加速開發微型化的「晶片實驗室」系統，該系統將DNA擴增化學與微流體技術結合。這項創新能夠精確處理微量樣本，顯著降低試劑成本，同時在單一攜帶式試劑盒內實現高通量並行處理。這些緊湊、快速反應的設備在分散式醫療環境中具有特別顯著的市場影響力，因為在這些環境中，速度至關重要。例如，生物梅里埃公司在2025年9月發布的「2025年上半年財務表現」報告中指出，其照護現場分子診斷解決方案SPOTFIRE系統的銷售額達到7,900萬歐元，內部成長143%。

另一項重要進展是多重擴增試劑盒的廣泛應用，該試劑盒可在單次反應中檢測和擴增多個DNA標靶。這項技術能夠同時識別多種遺傳標記和病原體，從而簡化法醫分析和感染疾病診斷的工作流程，節省耗材和時間。丹納赫公司於2025年10月發布的2025年第三季財務報告顯示，市場對這些多標靶檢測的需求強勁。該公司子公司Sepede報告稱，其核心非呼吸道檢測項目實現了強勁的個位數成長，這主要得益於性健康多重檢測收入約20%的成長。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球DNA擴增試劑盒市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（PCR、等溫擴增）
    • 依用途（臨床用途、研究用途）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美DNA擴增試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲DNA擴增試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區DNA擴增試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東與非洲DNA擴增試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲DNA擴增試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球DNA擴增試劑盒市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Cytiva lifesciences
  • Thermo Fisher Scientific Inc.
  • Sigma-Aldrich Solutions
  • QIAGEN NV
  • Jiangsu Cowin Biotech Co Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19789

The Global DNA Amplification Kit Market is projected to expand from USD 1,150.31 Million in 2025 to USD 1,675.63 Million by 2031, registering a CAGR of 6.47%. These kits comprise specialized enzyme mixtures and reagent sets essential for the exponential replication of target nucleic acid sequences, serving critical roles in clinical diagnostics and life science research. The market's growth is fundamentally anchored by the increasing prevalence of infectious diseases and the growing incorporation of molecular diagnostics into personalized oncology treatments. These enduring drivers ensure sustained long-term demand, distinguishing them from temporary industry fluctuations such as supply chain shifts or short-term regulatory changes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1,150.31 Million
Market Size 2031USD 1,675.63 Million
CAGR 2026-20316.47%
Fastest Growing SegmentPCR
Largest MarketNorth America

Despite this positive outlook, the substantial capital investment required for advanced amplification instrumentation poses a major hurdle to market growth in resource-constrained environments. This financial barrier restricts accessibility in developing regions and hinders the broad adoption of automated solutions. Highlighting the economic magnitude of the sector, MedTech Europe estimated the 2024 European medical technology market at 170 billion euros, with in vitro diagnostics emerging as the largest segment. This data underscores the significant economic scale of the diagnostic landscape in which DNA amplification products operate.

Market Driver

The rising incidence of genetic disorders and infectious diseases acts as a primary engine for the Global DNA Amplification Kit Market, generating continuous demand for molecular diagnostic tools. As global health continues to face challenges from pathogens like tuberculosis and respiratory viruses, the dependence on precise detection methods such as polymerase chain reaction (PCR) assays has grown significantly. This reliance is reflected in the financial results of major diagnostic providers supplying necessary reagents and enzymes; for instance, Qiagen reported in their February 2025 'Fourth Quarter and Full-Year 2024 Results' that their diagnostic solutions, specifically the QIAstat-Dx and QuantiFERON portfolios, achieved double-digit growth, highlighting the urgent requirement for reliable testing infrastructure.

Concurrently, the vigorous expansion of research and development within the biotechnology and pharmaceutical sectors is boosting the consumption of amplification kits used in drug discovery and genomic sequencing. Biopharmaceutical firms are allocating massive investments toward developing targeted therapies, a process necessitating large quantities of consumables for validation and genetic analysis. Underscoring this financial commitment, Roche's January 2025 'Annual Report 2024' noted R&D expenses of 13.0 billion CHF. This research-heavy landscape guarantees a steady revenue stream for manufacturers, as evidenced by Illumina's February 2025 'Form 10-K', which reported core consumables revenue of $3.17 billion, demonstrating the immense value of reagent-based products in the genomic ecosystem.

Market Challenge

The substantial capital investment needed for advanced amplification instruments serves as a major obstacle to the growth of the Global DNA Amplification Kit Market. Although the kits are recurring consumables, their effective use relies entirely on the presence of costly automated processing platforms and thermal cyclers. In settings with limited resources, the inability to finance this initial infrastructure creates a bottleneck that precludes the subsequent procurement of reagents. As a result, manufacturers are unable to reach a significant segment of potential customers in developing regions, which effectively limits the total volume of kit sales despite the urgent clinical demand for diagnostics in those areas.

This financial pressure is exacerbated by increasing operational costs within the sector, which hinder the ability to significantly reduce equipment prices. Survey data released by MedTech Europe in 2025 indicates that in vitro diagnostic manufacturers are contending with a 70% rise in spending on re-certification and regulatory maintenance over a five-year cycle. Such a marked increase in overhead expenses restricts manufacturers' flexibility to lower entry costs for new laboratories. Consequently, the high barrier to entry remains in place, directly constraining the broader adoption of DNA amplification technologies.

Market Trends

Manufacturers are increasingly combining DNA amplification chemistries with microfluidic technologies to develop miniaturized "Lab-on-a-Chip" systems. This innovation permits the precise handling of tiny sample volumes, which significantly lowers reagent costs while facilitating high-throughput parallel processing in a single, portable kit. The market impact of these compact, rapid-response devices is evident in decentralized healthcare settings where speed is paramount; for example, bioMerieux reported in their September 2025 'First-Half 2025 Financial Results' that sales of the SPOTFIRE system, a point-of-care molecular solution, reached €79 million, representing a 143% organic increase over the prior year.

Another significant advancement is the widespread adoption of multiplex amplification kits, which are designed to detect and amplify multiple DNA targets within a single reaction. This capability streamlines workflows in forensic analysis and infectious disease diagnostics by enabling the simultaneous identification of various genetic markers or pathogens, thereby conserving both consumables and time. The strong market demand for these multi-target assays is highlighted by Danaher Corporation's October 2025 'Q3 2025 Financial Results', where its subsidiary Cepheid noted high single-digit growth in its core non-respiratory menu, driven by an approximate 20% rise in sexual health multiplex testing revenue.

Key Market Players

  • Cytiva lifesciences
  • Thermo Fisher Scientific Inc.
  • Sigma-Aldrich Solutions
  • QIAGEN NV
  • Jiangsu Cowin Biotech Co Ltd

Report Scope

In this report, the Global DNA Amplification Kit Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA Amplification Kit Market, By Type

  • PCR
  • Isothermal Amplification

DNA Amplification Kit Market, By Application

  • Clinical
  • Research

DNA Amplification Kit Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA Amplification Kit Market.

Available Customizations:

Global DNA Amplification Kit Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global DNA Amplification Kit Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (PCR, Isothermal Amplification)
    • 5.2.2. By Application (Clinical, Research)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America DNA Amplification Kit Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States DNA Amplification Kit Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada DNA Amplification Kit Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico DNA Amplification Kit Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe DNA Amplification Kit Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany DNA Amplification Kit Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France DNA Amplification Kit Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom DNA Amplification Kit Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy DNA Amplification Kit Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain DNA Amplification Kit Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific DNA Amplification Kit Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China DNA Amplification Kit Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India DNA Amplification Kit Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan DNA Amplification Kit Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea DNA Amplification Kit Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia DNA Amplification Kit Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa DNA Amplification Kit Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia DNA Amplification Kit Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE DNA Amplification Kit Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa DNA Amplification Kit Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America DNA Amplification Kit Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil DNA Amplification Kit Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia DNA Amplification Kit Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina DNA Amplification Kit Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global DNA Amplification Kit Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cytiva lifesciences
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Sigma-Aldrich Solutions
  • 15.4. QIAGEN NV
  • 15.5. Jiangsu Cowin Biotech Co Ltd

16. Strategic Recommendations

17. About Us & Disclaimer